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Background: Multi-resistant bacteria (MRB) are an emerging problem. Early identification
of patients colonized with MRB is mandatory to avoid in-hospital transmission and to target
antibiotic treatment. Since most patients pass through specialized emergency depart-
ments (EDs), these departments are crucial in early identification. The Danish National
Board of Health (DNBH) has developed exposure-based targeted screening tools to identify
and isolate carriers of meticillin-resistant Staphylococcus aureus (MRSA) and
carbapenemase-producing Enterobacteriaceae (CPE).
Aim: To assess the national screening tools for detection of MRSA and CPE carriage in a
cohort of acute patients. The objectives were to investigate: (i) if the colonized patients
were detected; and (ii) if the colonized patients were isolated.y Department, Hospital Sønderjylland, Kresten Philipsensvej 15, 6200 Aabenraa, Denmark.
dk (H. Skjøt-Arkil).
Elsevier Ltd on behalf of The Healthcare Infection Society. This is an open access article
ivecommons.org/licenses/by-nc-nd/4.0/).
al., Detection of meticillin-resistant Staphylococcus aureus and carbapenemase-producing Enter-
ents e evaluation of national screening guidelines, Journal of Hospital Infection, https://doi.org/
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IsolationPlease cite this article as: Skjøt-Arkil H et
obacteriaceae in Danish emergency departm
10.1016/j.jhin.2019.08.024Methods: This was a multi-centre cross-sectional survey of adults visiting EDs. The
patients answered the DNBH questions, and swabs were taken from the nose, throat and
rectum. The collected samples were examined for MRSA and CPE. Screening performances
were calculated.
Findings: Of the 5117 included patients, 16 were colonized with MRSA and four were
colonized with CPE. The MRSA screening tool had sensitivity of 50% [95% confidence
interval (CI) 25e75%] for carrier detection and 25% (95% CI 7e52%) for carrier isolation.
The CPE screening tool had sensitivity of 25% (95% CI 1e81%) and none of the CPE carriers
were isolated.
Conclusion: The national screening tools were of limited use as the majority of MRSA and
CPE carriers passed unidentified through the EDs, and many patients were isolated
unnecessarily.
ª 2019 The Authors. Published by Elsevier Ltd
on behalf of The Healthcare Infection Society. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Infections caused by multi-resistant bacteria (MRB) con-
stitute a rapidly growing challenge in many parts of the world
[1], including Denmark. Early identification of patients
colonized with MRB is mandatory to avoid in-hospital trans-
mission and to target antibiotic treatment to the individual
patient.
As most patients admitted to hospitals in Denmark pass
through emergency departments (EDs), these departments
are crucial in early identification of patients colonized with
MRB. The authors have recently found the prevalence of
MRB-colonized patients in Danish EDs to be 5.2% [extended-
spectrum beta-lactamase-producing bacteria (4.5%),
meticillin-resistant Staphylococcus aureus (MRSA) (0.3%),
carbapenemase-producing Enterobacteriaceae (CPE) (0.1%)
and vancomycin-resistant enterococci (0.4%)] [2].
One of two strategies is currently recommended to detect
patients with MRB on admission to hospital: (i) universal
screening of all patients, which is simple but costly; or (ii)
targeted, exposure-based screening (questions determine risk
of colonization and need for screening), which is less expensive
[3] but far more complex, and holds a greater risk of missing
some MRB carriers [4]. Most experience has been obtained from
MRSA screening programmes, but even for MRSA there is no
clear consensus; for example, Scotland [4], Ireland [5] and
Denmark [6] have found targeted screening to be cost-
effective whilst parts of England have replaced targeted
screening with universal screening [7].
In 2016, the Danish National Board of Health published the
third edition of the guidelines for targeted screening for MRSA,
which was based on a few questions regarding exposures and an
individual risk assessment [6]. To date, only one single-site
study has evaluated the effectiveness of this approach. It
concluded that the screening algorithm only detected 18e27%
of the MRSA-colonized patients and only isolated 9% [8].
Recently, a targeted-exposure-based screening for CPE has
been implemented in Danish hospitals [9].
The aim of this study was to assess the exposure-based
targeted screening tools for detection of MRSA and CPE car-
riage in a cohort of acute patients. The objectives were to
investigate: (i) if colonized patients were detected; and (ii) if
colonized patients were isolated.al., Detection of meticillin-re
ents e evaluation of nationaBased on a single-site study evaluating MRSA screening [10],
it was hypothesized that the screening tools would only detect
a minority of colonized patients.Methods
Study design
This study is part of a Danish national multi-centre study:
the AntiBiotic Resistance in Emergency Departments (AB-RED)
study. Detailed information is available in the published pro-
tocol [11]. The AB-RED study was designed as a descriptive and
analytic cross-sectional survey of acute patients visiting Danish
EDs.
This study was designed in accordance with the Standards
for Reporting of Diagnostic Accuracy Studies guidelines [12].Study setting
The project took place in EDs at four university hospitals
(Odense University Hospital, Aarhus University Hospital, Aal-
borg University Hospital and Zealand University Hospital) and
four regional hospitals (Slagelse Hospital, Hospital of Southern
Jutland, Regional Hospital West Jutland and North Denmark
Regional Hospital). These eight EDs represented four of the five
Danish regions; the capital region did not participate in the
study.Participants, enrolment and procedure
Patients aged >18 years who presented to the EDs were
invited to participate. Patients were excluded if they were
unable to give informed consent (e.g. mental incompetence or
language barrier), if they had been admitted >16 h before
enrolment, or if swabs could not be obtained for anatomical or
surgical reasons. Repeated inclusion of the same patient was
accepted if related to a new acute admission.
According to the study protocol, only patients visiting an ED
for 4 h were eligible for inclusion. Due to organizational dif-
ferences in the EDs, it was impossible to maintain this criterion;
as such, the study protocol was altered to include all visiting
patients.sistant Staphylococcus aureus and carbapenemase-producing Enter-
l screening guidelines, Journal of Hospital Infection, https://doi.org/
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staff, and the study took place between January and April
2018, mainly on weekdays. Patients who agreed to participate
were interviewed and swabbed.
Interview
The interview was carried out by the project employees and
was based on the screening tools from the Danish National
Board of Health’s guidance on preventing the spread of CPE [9]
and MRSA [6].
In the MRSA guideline, risk assessment is based on three sets
of criteria: (i) general risk factors (mandatory questions to all
patients); (ii) special risk factors; and (iii) individual risk fac-
tors [6]. If a general and/or special risk factor is identified, the
patient must be swabbed and tested for MRSA colonization. In
addition, the patient must be isolated in certain predefined
high-risk situations. Criteria for swab testing and isolation are
listed in Table I.
The CPE guideline is very similar to the MRSA guideline, and
consists of: (i) general risk factors; and (ii) special risk factors.
If a risk factor is identified, the patient should be swabbed and
tested for CPE colonization, and in special situations, the
patient must be isolated. The criteria for swab testing and
isolation are listed in Table I.
Deviations from the screening tools
Patients often found it difficult to recall previous colo-
nization [8] or previous questioning [13], and the authors’
clinical experience indicates that it is even more difficult for
patients to recall and distinguish between different MRB. It was
therefore decided to reword the questions marked with an
asterisk (*) in Table I to include ‘resistant bacteria’ instead of
MRSA and CPE; for example, the first question was modified to
‘Have you previously been colonized with resistant bacteria?’
The two questions regarding MRSA/CPE outbreak marked with
** in Table I were not included in the study, and neither was the
question regarding dialysis and antineoplastic treatment in the
CPE screening tool. The answer was only based on the inter-
view and was not checked in the health records.
Collection of swabs and microbiological analysis
Immediately after the interview, patients were swabbed in
the nose, throat and rectum. The collected samples were
examined for MRSA and CPE at the Departments of Clinical
Microbiology at Aalborg University Hospital, Aarhus University
Hospital, Odense University Hospital and Slagelse Hospital. The
same method of analysis was applied at all four departments.
All analyses followed the procedure described in the protocol
article without deviations [11].
Data management and analysis
A patient-level database was constructed to include
laboratory test results and collected questionnaire data.
Data analyses were conducted in STATA 14. The laboratory
test results were the standard reference. Screening per-
formance was calculated for five different MRSA screening
models: ability to detect MRSA based on (i) general risk
factors, (ii) special risk factors, (iii) individual risk factors,
(iv) a combination of all risk factors, and (v) need for iso-
lation. For CPE, screening measures were calculated for
three different screening models: ability to detect CPEPlease cite this article as: Skjøt-Arkil H et al., Detection of meticillin-re
obacteriaceae in Danish emergency departments e evaluation of nationa
10.1016/j.jhin.2019.08.024based on (i) general risk factors, (ii) special risk factors, and
(iii) need for isolation. For all analyses, sensitivity, specif-
icity, positive predictive value, negative predictive value,
accuracy and likelihood of a positive and negative test were
calculated. For all screening measures, 95% confidence
intervals (CI) were calculated. Detailed information about
sample size calculation is given elsewhere [11].
Ethical approval and consent to participate
The project was approved by the Regional Committees on
Health Research Ethics for Southern Denmark (No. S-
20170182), approved by the Danish Data Protection Agency
(Journal No. 17/44444), and registered at clinicaltrials.gov
(NCT03352167). Informed written consent was obtained from
all participants before inclusion in the study. The patients had
the right of revocation in which case the patient data would be
deleted from the study.
Results
Of 5117 participants with a median age of 68 years (inter-
quartile range 54e77 years) and an equal gender distribution,
16 patients (0.3%, 95% CI 0.2e0.5%) colonized with MRSA and
four patients colonized with CPE (0.08%, 95% CI 0.0e0.2%) were
identified. Further details are published elsewhere [2].
MRSA screening tool
The general risk factors identified 181 of 5117 patients
where a MRSA swab test was required, but only five of the 16
colonized patients were identified, resulting in sensitivity of
31% (95% CI 11e59%) (Table II). Eleven of the 16 MRSA-colonized
patients remained undetected. The special risk factors
detected none of the MRSA-colonized patients. Both the indi-
vidual risk factors and the combination of general risk factors,
special risk factors and individual risk factors had sensitivity of
50% (95% CI 24e75). According to the defined isolation criteria,
133 patients should have been isolated. Among these were four
of the 16 MRSA-colonized patients, resulting in a positive pre-
dictive value of 3% (95% CI 1e8). The remaining 129 patients
(2.5% of all visits) would have been isolated without having
MRSA. The likelihood ratios for a negative test were close to 1
for all five models, indicating a minimal association between
the screening models and MRSA colonization.
CPE screening tool
According to the general risk factors, a CPE swab test was
required in 163 of 5117 patients, but only one of the four
colonized patients was identified, resulting in sensitivity of 25%
(95% CI 1e81%) (Table III). The special risk factors did not
detect any of the CPE-colonized patients. None of the four CPE-
colonized patients would have been isolated according to the
screening tool, while 75 patients (1.5% of all visits) would have
been isolated due to incorrect suspicion of CPE.
Discussion
The MRSA screening tool identified 31% of the patients
colonized with MRSA, and only 25% of the MRSA-colonizedsistant Staphylococcus aureus and carbapenemase-producing Enter-
l screening guidelines, Journal of Hospital Infection, https://doi.org/
Table I
Criteria for swab testing and isolation according to the meticillin-resistant Staphylococcus aureus (MRSA) and carbapenemase-producing
Enterobacteriaceae (CPE) screening tools
Screening tool Questions
MRSA Swab e general risk factors
Previously been colonized with MRSA?a
Household contact with an MRSA-colonized person within last 6 months?a
Stayed in a clinic/hospital outside the Nordic countries and stayed for >24 h or underwent invasive procedures
during the stay?
Weekly or more frequent contact with living pigs or household contact with a person with contact with living
pigs?
Swab e special risk factors
Daily stay in hospital, nursing home or similar situation with MRSA outbreak?b
Worked in hospital, nursing home or similar in foreign country?
Daily stay in poor hygienic conditions (e.g. asylum centre, refugee camp, homeless shelter, disaster or war
zone)?
Daily contact with mink farm or lived with a person who had daily contact with mink farm?
Daily contact with persons who have lived in a foreign country?
Stayed in a foreign country and has signs of staphylococcus infection, especially if been to prison, shared sports
equipment or had tattoos/piercings performed?
Swab e individual risk factors
Wounds, recurrent abscesses, chronic skin conditions, chronic respiratory infections, indwelling catheters or
tubes, and intravenous drug abuse?
Isolation
Previously been colonized with MRSA and not declared MRSA-free?
Stayed for >24 h in a clinic/hospital outside the Nordic countries within the last 7 days?
Had weekly or more frequent contact with living pigs?
CPE Swab e general risk factors
Previously been colonized with CPE?a
Household contact with a CPE-colonized person within last 6 months?a
Stayed in a clinic/hospital outside the Nordic countries and stayed for >24 h or underwent invasive procedures
during the stay?
Stayed in a foreign country while receiving antibiotic treatment within the last 6 months?
Swab e special risk factors
Daily stay in hospital, nursing home or similar situation with CPE outbreak?b
Daily stay in poor hygienic conditions (e.g. asylum centre, refugee camp, homeless shelter, disaster or war
zone)?
Been on dialysis treatment or received antineoplastic medical treatment?b
Isolation
Previously been colonized with CPE?
Daily stay for >24 h in a clinic/hospital outside the Nordic countries within the last 7 days?
a The question was modified to included ‘resistant bacteria’ instead of either MRSA or CPE.
b This question was not included in the study.
H. Skjøt-Arkil et al. / Journal of Hospital Infection xxx (xxxx) xxx4patients were isolated. In addition, the majority of isolations
(97%) were unnecessary.
The CPE screening tool identified one out of four CPE car-
riers, and none of the CPE carriers were isolated. Thus all
isolations were unnecessary, while 75% of the colonized
patients passed through the ED without being swab tested.
Despite revisions to the MRSA screening tool in 2016, sensi-
tivity remained low in this multi-site study. However, the
challenge might be that the prevalence of MRSA carriers in
Denmark is so low that it is difficult to develop a robust algo-
rithm and thus a screening tool with sufficient sensitivity and
specificity. The screening tools by the Danish National Board of
Health might have been developed under the assumption that
resistance will increase over time, and it is possible that the
tools would be more useful in a high-prevalence setting. It
seems unlikely that the performance of the screening tool isPlease cite this article as: Skjøt-Arkil H et al., Detection of meticillin-re
obacteriaceae in Danish emergency departments e evaluation of nationa
10.1016/j.jhin.2019.08.024negatively affected by the longstanding Danish policies for
MRSA screening and carrier treatment, as MRSA prevalence has
risen significantly in the last 10 years.
Isolation is costly and known to be associated with adverse
effects and treatment complications, so it seems important,
especially in a low-prevalence setting, to weigh the benefits
related to the low number of correctly isolated patients against
the unnecessary use of isolation [14e16].
Targeted, exposure-based screening is complex, requires
trained staff, is estimated to take approximately 7 min per
patient [8], might interfere with the handling of acutely ill
patients, and appears to perform poorly in a low-prevalence
setting. In addition, the screening tool might perform more
poorly in a non-study setting, as staff compliance is likely to
be associated with a number of different factors (e.g. inte-
gration and prioritization of screening in the admissionsistant Staphylococcus aureus and carbapenemase-producing Enter-
l screening guidelines, Journal of Hospital Infection, https://doi.org/
Table II
Evaluation of the meticillin-resistant Staphylococcus aureus screening tool to detect which patients should be swabbed and which should
be isolated
Swab e general
risk factors
Swab e special
risk factors
Swab e individual
risk factors
Swab e general,
special and individual risks
Isolation
Number of patients 181 150 1786 1964 133
True positive 5 0 8 8 4
True negative 4925 4951 3323 3145 4972
False positive 176 150 1778 1956 129
False negative 11 16 8 8 12
Screening values
Sensitivity 31% (11e59) 0% (0e21) 50% (24e75) 50% (25e75) 25% (7e52)
Specificity 97% (96e97) 97% (97e98) 65% (63e67) 62% (60e63) 98% (97e98)
PPV 3% (1e6) 0 (0.0e2.4) 0.4% (0.2e0.9) 0.4% (0.2e0.8) 3% (1e8)
NPV 100% (100e100) 100% (100e100) 100% (100e100) 100% (100e100) 100% (100e100)
Accuracy 96% (96e97) 98% (96e97) 65% (64e66) 62% (60e63) 97% (97e98)
Likelihood ratios
Positive test 9.1 (4.3e19.0) 0 (e) 1.4 (0.9e2.3) 1.3 (0.8e2.1) 9.9 (4.2e23.5)
Negative test 0.7 (0.5e1.0) 1.0 (1.0e1.0) 0.8 (0.5e1.3) 0.8 (0.5e1.3) 0.8 (0.6e1.0)
PPV, positive predictive value; NPV, negative predictive value. 95% confidence intervals are indicated in brackets.
H. Skjøt-Arkil et al. / Journal of Hospital Infection xxx (xxxx) xxx 5process, monitoring/feedback, and local culture and beliefs)
[17].
Hence it seems necessary to evaluate other strategies. It
may well be possible to optimize the screening algorithm (e.g.
by combining different MRB in the same algorithm), but
nonetheless, it seems highly likely that performance will be
related to the prevalence of MRB. Universal screening is
another possibility, but will unavoidably rely on fast, costly
point-of-care testing, and may therefore not be cost-effective
in a low-prevalence setting [13].
The problems associated with unnecessary isolation may be
minimized by selective use of fast point-of-care testing, but
patients who remain undetected in the screening programme
will still be an unknown, possible source of in-hospital trans-
mission. It is possible, however, that a high general infection
control standard is sufficient to hinder transmission. This is
supported by observations from Denmark where exposure/risk-
based screening was introduced by the health authorities inTable III
Evaluation of the carbapenemase-producing Enterobacteriaceae scree
should be isolated
Swab e general risk factors Swab e special
Number of patients 163 62
True positive 1 0
True negative 4951 5051
False positive 162 62
False negative 3 4
Screening values
Sensitivity 25% (1e81) 0% (0e6
Specificity 97% (96e97) 99% (98e
PPV 1% (0e3) 0% (0e6
NPV 100% (100e100) 100% (100e
Accuracy 97% (96e97) 97% (96e
Likelihood ratios
Positive test 7.9 (1.4e43.5) 0 (e)
Negative test 0.8 (0.4e1.4) 1.0 (1.0e
PPV, positive predictive value; NPV, negative predictive value. 95% confide
Please cite this article as: Skjøt-Arkil H et al., Detection of meticillin-re
obacteriaceae in Danish emergency departments e evaluation of nationa
10.1016/j.jhin.2019.08.0242006. In spite of the fact that the number of new community-
acquired MRSA cases has risen approximately 350% over the
past 10 years (3579 cases in 2017), and despite the low
screening sensitivity shown in this study, the number of
hospital-acquired cases has remained low and almost constant
(approximately 50 cases/year) [18]. A high general infection
control standard is supported by other studies which favour a
prevention approach, focusing on body washes with anti-
septics, hand hygiene compliance and antibiotic stewardship,
compared with a pathogenic-specific approach, based on
screening, isolation and eradication [19].
Strength and limitations
The strength of this study is that it was the first multi-centre
study to assess the performance of two national screening
tools. However, the study also had some limitations. First, the
patients were asked to recall previous colonization withning tool to detect which patients should be swabbed and which
risk factors Swab e general and special risks Isolation
223 75
1 0
4891 5038
222 75
3 4
0) 25% (1e81) 0% (0e60)
99) 96% (95e96) 99% (98e99)
) 0% (0e2) 0% (0e5)
100) 100% (100e100) 100% (100e100)
97) 96% (95e96) 98% (98e99)
7.9 (1.4e43.5) 0.0 (e)
1.0) 0.8 (0.4e1.4) 1.0 (1.0e1.0)
nce intervals are indicated in brackets.
sistant Staphylococcus aureus and carbapenemase-producing Enter-
l screening guidelines, Journal of Hospital Infection, https://doi.org/
H. Skjøt-Arkil et al. / Journal of Hospital Infection xxx (xxxx) xxx6resistant bacteria instead of previous colonization with MRSA or
CPE. This change might have increased the number of false-
positive results. Second, questions regarding MRSA/CPE out-
breaks and dialysis/antineoplastic therapy were not included
in the study. This deviation might have decreased the number
of true- and false-positive patients in some of the screening
models. Third, only 16 MRSA carriers and four CPE carriers were
identified in the study, resulting in wide CIs. Fourth, some
patients might have been unwilling to participate because they
feared that they were colonized with MRB, and hence at risk of
additional treatments, isolation and possibly stigmatization.
Fifth, the questions were based on past events and required a
certain level of recall ability for the acutely ill patient. This
might increase the number of false-negative and -positive
results. The last two limitations apply generally to risk-based
screening.
In conclusion, the exposure-based targeted screening
guidelines for MRSA and CPE carriage published by the Danish
National Board of Health were of limited use as the majority of
MRSA and CPE carriers passed unidentified through the EDs, and
many patients were isolated unnecessarily.
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